-
04.08.2026 | One Health : des « Engagements de Lyon » à une approche mondiale
PHARMACEUTIQUES | Organisé à Lyon, le One Health Summit veut marquer un tournant stratégique, de la prévention des pandémies à la lutte contre la résistance aux antimicrobiens.
-
04.08.2026 | EU pledges €700m to Global Fund to tackle worldwide health challenges
INNOVATION NEWS NETWORK | The European Commission has announced plans to commit €700m to the Global Fund, reinforcing its position as a central player in global health financing.
-
04.08.2026 | EU invests €30m to fight antimicrobial resistance
PHARMAPHORUM | The EU has pledged €30 million ($35 million) in funding for medical countermeasures to antimicrobial resistance (AMR), earmarked for the discovery and development of new antibacterial medicines.
-
04.07.2026 | Global agreement announced at G7 One Health Summit to accelerate access to diagnostics and responses to rising health threats
BIOMERIEUX | A coalition of more than 20 international partners announced the Global One Health Diagnostics Access Compact (GO-Dx) during the G7 One Health Summit in Lyon, France.
-
03.30.2026 | Lægemiddelresistens – en global sundhedskrise
NOVO NORDISK FOUNDATION | Dette er den fjerde del i en serie af vores administrerende direktør, Mads Krogsgaard Thomsen, om, hvordan Novo Nordisk Fonden er i forandring.
-
01.30.2026 | In brief this week: Natera, Revvity, Becton Dickinson, Wellcome, CARB-X
360DX | Global charitable organization Wellcome and the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced this week that they haverenewed their partnership.
-
01.29.2026 | CARB-X receives $60 million from Wellcome to support early-stage antibiotic R&D
CIDRAP | CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) said yesterday that it will receive $60 million in funding over the next two years from global charitable foundation Wellcome.
Toggle navigation